Oscar Health, Inc. (NYSE:OSCR) Q3 2022 Earnings Call Transcript

Page 5 of 5

And the final point I would make is the work we are doing internally on continuing to stabilize and enhancing operations is all work that will make an eventual bigger +O products better as well. So, that’s keeping continuing the year, but it’s a very big overlap. Now, on MA excess, I am glad you bring this up, and we did, in fact, largely do that. We exited our organic MA business in New York and in Texas. And that was not that material to membership and €“ but it did help the insurance company on performance on the medical loss ratio, administrative ratio and things like that for next year. And we did that with exact an eye towards this increased focus, we are really good at as we believe at ACA plans and vital family funds you say, and we want to be focused there.

And MA market is a market we want to eventually go back do more in, but the way for us to be in this market is through partners. And that, again, is a future of +O a business and even the current folks we are working with there. So, that’s to your question exactly a welcome focus and let’s just make sure we land over the planes, we get a land for next year.

Scott Blackley: And Josh, on €˜23 planning and outlook, I have been leading that process and building our internal budgets and outlook for 2023. I will be working with Sid closely over the rest of this year to transition that over to him where he will take that on. And as we talked about, we will formally be transitioning CFO role on December 1st, but I expect to arrive promptly at 8 a.m. in my office tomorrow, and we will start working on that transition. But the one thing I would just say is having someone who is deeply familiar with the company makes that process and transition a much easier thing and it gives me the liberty to move over to help drive the execution of some of the key plans that we have got in place for 2023.

Mario Schlosser: And Josh you asked the last question you asked about permanent CFO. As I have said, this is really for us about focusing on these big goals we have €˜23 profitability, total cohort €˜24 profitability by this call next year, I think we have good visibility into €˜23 in total profitability. And that is how long we think will all work together with this, and it gives us plenty of time to then figure out what the next steps are beyond that. But we are fired up to work together. I see all of us here, Alexa there as well, Ramli as well and in good shape there for the adventures to come.

Josh Raskin: Makes sense. Thank you.

Operator: There are no further questions at this time. This does conclude today’s conference call. Thank you for joining. You may now disconnect.

Follow Oscar Health Inc. (NYSE:OSCR)

Page 5 of 5